Get the StoQuant digest — free

Free StoQuant digest by email. No account needed. See today's research picks.

Subscribe free

ABBV vs AZN — Stock Comparison

Compare ABBV and AZN side-by-side on StoQuant: ABBV Q-Score 91 vs AZN 45; analyst signal 58 vs 61. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.

Side-by-side snapshot

• ABBV — ABBVIE INC · Health Care · market cap $506.17B · Q-Score verdict Strong Buy (91.0, grade A) · analyst signal 58/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: earnings quality 96/100, technicals 92/100 · weakest signals: ML forecast 49/100, analyst consensus 21/100. Full ABBV research.
• AZN — AstraZeneca PLC · Health Care · market cap $263.77B · Q-Score verdict Hold (45.0, grade C) · analyst signal 61/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: technicals 37/100, analyst consensus 28/100 · weakest signals: ML forecast 5/100. Full AZN research.

What you can compare

• Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
• Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
• Insider activity: Cluster scores and recent Form 4 buying.
• Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
• Strategic edges: Competitive moat and durable advantage analysis.
• Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
• Macro context: Market regime and sector rotation alignment.

Deep dive: ABBV research · AZN research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →